It looks like the ticker $BEAT is primarily associated with HeartBeam, Inc., which is a medical device company. Previously, it was the ticker for BioTelemetry, Inc., which was acquired.
Here is a summary of the latest analysis and short interest information found for HeartBeam, Inc. ($BEAT):
📈 Latest Stock Analysis & Forecast (HeartBeam, Inc.)
Recent Price Action (as of Dec 15, 2025): The stock price reportedly gained 14.63% on the last trading day, rising from \$2.29 to \$2.63. It has gained for 4 consecutive days and is up 264.58% over the preceding two weeks.
Short-Term Signals: There were mostly positive signals from both short and long-term Moving Averages, giving a positive forecast for the stock in the short-term.$BEAT
Short-Term Recommendation: The current level may be a buying opportunity as there's a fair chance for the stock to perform well in the short-term, despite being in a falling long-term trend.
Support Level: The stock finds support around \$2.29 and \$2.13.
3-Month Forecast: A prediction suggests the stock is expected to fall -17.23% over the next 3 months, with a 90% probability of holding a price between \$0.389 and \$2.17.
📉 Short Interest Metrics (HeartBeam, Inc. - BEAT)
As of the last reported settlement dates, the short interest figures indicate a low risk of a significant short squeeze.$PIPPIN #CPIWatch #USJobsData #WriteToEarnUpgrade #BTCVSGOLD #BinanceBlockchainWeek
